Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Editorial - (2021) Volume 0, Issue 0

Editorial on the Scope and Archives of International Journal of Drug Development and Research

Satoru*

University of Tokyo, Department of physical medicine, Tokyo 113-8654, Japan

*Corresponding Author:
Satoru
University of Tokyo
Department of physical medicine
Tokyo 113-8654
Japan
E-mail: Satoru@163.com

Received Date: February 3, 2021; Accepted Date: February 17, 2021; Published Date: February 24, 2021

Citation: Satoru (2021) Editorial on the Scope and Archives of International Journal of Drug Development and Research , Int J Drug Dev & Res Vol.13 No.S1: e001

Visit for more related articles at International Journal of Drug Development and Research

Description

In this pandemic circumstances drug improvement and exploration has acquired a huge significance. Medication advancement exclusively implies a conclusive goal of drug improvement to bring another compound with exhibited helpful effect available. This Journal named "International Journal of Drug Development and Research" has given an incredible open door for specialists and different experts to mindful about the most recent medication disclosures.

International Journal of Drug Development and Research (IJDDR) distributes full length research reports, audit articles and logical critiques and correspondence on all parts of the drug sciences with solid sciences with solid accentuation on curiosity, innovation and logical quality. The Editors invite articles in this multidisciplinary field, going from Drug Development to Drug Discovery. All the more explicitly, the Journal distributes reports in therapeutic science, pharmacology, drug assimilation and digestion, pharmacokinetics and pharmacodynamics, drug and biomedical examination, drug conveyance frameworks including quality conveyance, drug focusing on, drug innovation, drug biotechnology and clinical medication assessment.

In this Journal, An article named “Design and Development of Nifedipine Extended Release Tablet Double Rotary Bi- Layered Compression Machine” written by author Sunita S Shinde describes of Nifedipine expanded delivery tablet 90 mg by two fold revolving bi layered pressure machine that can give consistent medication delivery to time of 24 hours. This formulation allows for single daily dose Another interesting component of this framework is that every tablet is defined with 10% more medication than tablet strength shows.

Another article named “Formulation and evaluation of Herbal Oral Gel Containing Extracts of Powdered Psidium guajava Linn Leaves with Curcuma longa Linn Rhizomes to Treat Mouth Ulcer” by Richa Sing , The target of this investigation was to define and assess the natural oral gel containing concentrates of powdered Psidium guajava Linn leaves and Curcuma longa Linn rhizomes to treat mouth ulcer.

Characteristic cures are more worthy in the conviction that they are more secure with lesser results than the engineered meds. This new home grown gel which in detailing having great antifungal movement just as mitigating action so it is protected, steady and useful for mouth ulcer treatment.

“Potent Suppression of proliferation of Breast Carcinoma Cells by a Novel Anthranilic Acid derivate’ this article by the author Chelsea Reiber has gained huge importance in treating cancer. Chemotherapy stays the pillar treatment for the most meddlesome sort of bosom carcinoma, Triple Negative Breast Cancer (TNBC) that has a higher propensity for instinctive metastases, backslides, and helpless visualizations.

The counter proliferative impacts of GV6 are pretty much as powerful as BIBR1532 for both TNBC and non-TNBC cell types. Additionally, GV6 prompted a equivalent pace of senescence and down regulation of consistent state levels of hTERT mRNA inside the bosom carcinoma cells. Further examination is expected to affirm these discoveries and broaden examinations on investigating advantages of using this aliphatic chain subbed anthranilic corrosive in one or the other a combinatorial, adjuvant or neo adjuvant chemotherapeutic setting in contrast with BIBR1532.

35463